Previous Page  10 / 20 Next Page
Information
Show Menu
Previous Page 10 / 20 Next Page
Page Background

Page 44

conferenceseries

.com

Volume 7

Journal of Infectious Diseases & Therapy

Infectious Diseases & Endocrinology 2019

February 27-28, 2019

February 27-28, 2019 Tokyo, Japan

Infectious Diseases, Diabetes and Endocrinology

Global Experts Meeting on

J Infect Dis Ther 2019, Volume 7

DOI: 10.4172/2332-0877-C2-063

Prevalence and atherogenic index of plasma as a predictor of cardiometabolic syndrome amongst

road transport workers in Owerri

Charles Chukwuemeka Onoh

Federal University of Technology, Nigeria

C

ardiometabolic Syndrome is a constellation of cardiovascular risk factors which include diabetes, hypertension, obesity,

dyslipidaemia amongst others. The Atherogenic Index of Plasma (AIP) is the logarithm of molar ratio of Triglycerides

to High-Density Lipoprotein cholesterol (TG/HDL-cholesterol). This study was designed to determine the prevalence and

predictors of cardiometaboic syndrome among road transport workers. The study was a work- site based cross-sectional

study carried out on 120 workers at Imo Transport Corporation, Owerri. The questionnaires were designed to address the

background information of the respondents with respect to gender, age, job title, departments and address. The respondents

were anthropometrically examined. The prevalence was calculated as a ratio and reported in percentage. Principal Component

Analysis (PCA) and multinomial probit regression model were employed to determine the degree of relationship between the

AIP and cardiometabolic parameters and their order of importance. The prevalence of cardiometabolic syndrome was found

to be 19.17%. AIP was shown to be statistically significant and positively correlated with Waist Circumference (WC) and Body

Mass Index (BMI). AIP was shown to be a principal dominant predictor of cardiometabolic syndrome. AIP as a calculated

factor can be used in the clinical setting for assessing cardiometabolic syndrome beyond the routinely done lipid profile.

drcharlesonoh@gmail.com